K030616 is an FDA 510(k) clearance for the CEDIA CYCLOSPORINE PLUS HIGH RANGE CONTROLS 4 AND 5. Classified as Drug Specific Control Materials (product code LAS), Class I - General Controls.
Submitted by Microgenics Corp. (Fremont Blvd., US). The FDA issued a Cleared decision on March 31, 2003 after a review of 33 days - a notably fast clearance cycle.
This device falls under the Toxicology FDA review panel, regulated under 21 CFR 862.3280 - the FDA toxicology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.
View all Microgenics Corp. devices